Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | CXCR3 | P49682 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1298732 | 1.00 | SMN1; SMN2 (0.71) | SMN1; SMN2KDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL1298199 | 0.83 | SMN1; SMN2 (1.00) | SMN1; SMN2KDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL7285861 | 0.79 | MEN1 (0.75) | SMN1; SMN2L3MBTL1MEN1KMT2ACXCR3 | |
| SCHEMBL7285857 | 0.79 | MEN1 (0.75) | SMN1; SMN2L3MBTL1MEN1KMT2ACXCR3 | |
| SCHEMBL20762012 | 0.77 | F2 (0.50) | SMN1; SMN2KDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL22571722 | 0.77 | F2 (0.50) | SMN1; SMN2KDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL12107327 | 0.77 | L3MBTL1 (0.44) | SMN1; SMN2KDM4EL3MBTL1 | |
| SCHEMBL7301186 | 0.76 | — | — | |
| SCHEMBL7291424 | 0.76 | — | — | |
| SCHEMBL14465871 | 0.73 | CXCR3 (0.78) | CXCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2785688-B1 | A PROCESS FOR THE MANUFACTURE OF CHIRAL CATALYSTS AND THEIR SALTS | SCINOPHARM TAIWAN LTD (TW) | 2017-09-13 | — | — | EP | disclosed |
| US-8865893-B2 | Method for preparing 2-morpholinoisobornane-10-thiol and intermediates formed therein | NATIONAL TSING HUA UNIVERSITY (TW) | 2014-10-21 | — | — | US | disclosed |
| US-8865893-B2 | Method for preparing 2-morpholinoisobornane-10-thiol and intermediates formed therein | NATIONAL TSING HUA UNIVERSITY (TW) | 2014-10-21 | — | — | US | disclosed |
| US-8859765-B2 | Process for the manufacture of chiral catalysts and their salts | SCINOPHARM TAIWAN, LTD. (TW) | 2014-10-14 | — | — | US | disclosed |
| CN-102234255-B | Process for the preparation of 2-morpholinoisobutane-10-thiols and intermediates formed thereby | NAT UNIV TSING HUA | 2013-05-08 | — | — | CN | disclosed |
| CN-102234255-A | Process for the preparation of 2-morpholinoisobutane-10-thiols and intermediates formed thereby | NAT UNIV TSING HUA | 2011-11-09 | — | — | CN | disclosed |
| US-20110269955-A1 | METHOD FOR PREPARING 2-MORPHOLINOISOBORNANE- 10-THIOL AND INTERMEDIATES FORMED THEREIN | NATIONAL TSING HUA UNIVERSITY (TW) | 2011-11-03 | — | — | US | disclosed |
| US-20110269955-A1 | METHOD FOR PREPARING 2-MORPHOLINOISOBORNANE- 10-THIOL AND INTERMEDIATES FORMED THEREIN | NATIONAL TSING HUA UNIVERSITY (TW) | 2011-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269955-A1 | METHOD FOR PREPARING 2-MORPHOLINOISOBORNANE- 10-THIOL AND INTERMEDIATES FORMED THEREIN | MPST, TST, TMT1A | SMN1; SMN2 72/4885KDM4E 4287/4885L3MBTL1 523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.